To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis

This publication has 65 references indexed in Scilit:

• Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?
  Cells, 2012
• Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis
  Journal of Immunology Research, 2011
• Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots
  European Journal of Clinical Microbiology & Infectious Diseases, 2011
• Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe
  Clinical Microbiology and Infection, 2011
• Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: Survey of patients seen in general practice
  BMC Infectious Diseases, 2010
• CXCL13 as a Cerebrospinal Fluid Marker for Neurosyphilis in HIV-Infected Patients With Syphilis
  Sexually Transmitted Diseases, 2010
• Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls
  Clinical and Vaccine Immunology, 2009
• Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue
  Diagnostic Microbiology and Infectious Disease, 2008
• IgG Seroprevalence of Lyme borreliosis in the Population of the land Islands in Finland
  Scandinavian Journal of Infectious Diseases, 1998
• Lyme neuroborreliosis: A new sensitive diagnostic assay for intrathecal synthesis of borrelia burgdorferi–specific immunoglobulin G, A, and M
  Annals of Neurology, 1991